| |
|
|
|
Xtl Biopharma Ads  
|
|
3.21 0.11 (0.04%) |
03-01 16:00 |
|
Open: |
3.22 |
Pre close: |
3.1 |
Target:
|
4.17
|
|
High: |
3.23 |
Low: |
3.1674 |
Resistance:
|
3.57
4.05
|
|
Volume: |
4,751 |
Market Cap: |
16M |
Support:
|
2.80
2.33
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.19
 |
MACD |
MACD(12,26):
|
-0.03 |
|
MA(20): |
3.41  |
Signal(12,26,9): |
0.03 |
|
MA(100): |
2.82 |
Stochastic Oscillator |
%K(14,3):
|
28.53 |
|
MA(250): |
2.01 |
%D(3): |
29.96 |
|
Average Volume(K) |
3-Month: |
2952
|
52-Week |
High:
|
4.17 |
|
10-Days: |
1436 |
Low: |
0.63 |
|
RSI |
RSI(14):
|
46.21 |
Change(%): |
145.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.400 |
Return on Equity (ttm) |
-29.7 |
Shares Out. (M) |
5.14 |
|
EPS Est. Current Year |
-0.020 |
Return on Assets (ttm) |
-8.1 |
Shares Float (M) |
3.49 |
|
EPS Est. Next Year |
-0.020 |
PEG Ratio |
0.00 |
% Held by Insiders |
19.95 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
8.68 |
|
Forward EPS |
0.600 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
21 |
|
Book Value (p.s.) |
1.200 |
EBITDA (p.s.) |
0.000 |
P/E |
-8.02 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.67 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
